Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Blanco

Showing results (801-810 of 816) with videos related to

Pageof 82
Sort By:
JAMA|December 12, 2025
Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical TrialLaura J Esserman, Allison S Fiscalini, Arash Naeim, et al.
Human Mutation|May 22, 2019
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestryTara M Friebel, Irene L Andrulis, Judith Balmaña, et al.
Nature|December 20, 2019
Prediction and observation of an antiferromagnetic topological insulatorM M Otrokov, I I Klimovskikh, H Bentmann, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer riskDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
NPJ Genomic Medicine|November 20, 2025
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancerDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 16, 2020
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variantsDaniel R Barnes, Matti A Rookus, Lesley McGuffog, et al.
Nature|April 2, 2025
Global impoverishment of natural vegetation revealed by dark diversityMeelis Pärtel, Riin Tamme, Carlos P Carmona, et al.
Human Mutation|February 16, 2018
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutationsTimothy R Rebbeck, Tara M Friebel, Eitan Friedman, et al.
NPJ Breast Cancer|November 9, 2019
The <i>FANCM</i>:p.Arg658* truncating variant is associated with risk of triple-negative breast cancerGisella Figlioli, Massimo Bogliolo, Irene Catucci, et al.
Nature Genetics|January 9, 2020
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genesLaura Fachal, Hugues Aschard, Jonathan Beesley, et al.
Pageof 82

Showing results (801-810 of 816) with videos related to

Sort By:
Pageof 82
JAMA|December 12, 2025
Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical TrialLaura J Esserman, Allison S Fiscalini, Arash Naeim, et al.
Human Mutation|May 22, 2019
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestryTara M Friebel, Irene L Andrulis, Judith Balmaña, et al.
Nature|December 20, 2019
Prediction and observation of an antiferromagnetic topological insulatorM M Otrokov, I I Klimovskikh, H Bentmann, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer riskDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
NPJ Genomic Medicine|November 20, 2025
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancerDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 16, 2020
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variantsDaniel R Barnes, Matti A Rookus, Lesley McGuffog, et al.
Nature|April 2, 2025
Global impoverishment of natural vegetation revealed by dark diversityMeelis Pärtel, Riin Tamme, Carlos P Carmona, et al.
Human Mutation|February 16, 2018
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutationsTimothy R Rebbeck, Tara M Friebel, Eitan Friedman, et al.
NPJ Breast Cancer|November 9, 2019
The <i>FANCM</i>:p.Arg658* truncating variant is associated with risk of triple-negative breast cancerGisella Figlioli, Massimo Bogliolo, Irene Catucci, et al.
Nature Genetics|January 9, 2020
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genesLaura Fachal, Hugues Aschard, Jonathan Beesley, et al.
Pageof 82